Extracorporeal membrane oxygenation for acute respiratory distress syndrome due to Pneumocystis pneumonia

Eur Respir J. 2019 Sep 19;54(3):1900410. doi: 10.1183/13993003.00410-2019. Print 2019 Sep.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Body Weight
  • Dyspnea / therapy
  • Extracorporeal Membrane Oxygenation*
  • Female
  • HIV Infections / complications*
  • HIV Infections / therapy
  • Humans
  • Immunosuppression / adverse effects
  • Male
  • Middle Aged
  • Oxygen / metabolism
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / therapy*
  • Respiration, Artificial
  • Respiratory Distress Syndrome / complications
  • Respiratory Distress Syndrome / therapy*
  • Retrospective Studies
  • Shock, Septic

Substances

  • Oxygen